Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C19H22N2O3S |
| Molecular Weight | 358.455 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC2=C(C=C1)N(C=C2CCN(C)C)S(=O)(=O)C3=CC=CC=C3
InChI
InChIKey=AIJIQCBYMBZLJD-UHFFFAOYSA-N
InChI=1S/C19H22N2O3S/c1-20(2)12-11-15-14-21(19-10-9-16(24-3)13-18(15)19)25(22,23)17-7-5-4-6-8-17/h4-10,13-14H,11-12H2,1-3H3
| Molecular Formula | C19H22N2O3S |
| Molecular Weight | 358.455 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/11055342Curator's Comment: description was created based on several sources, including:
https://www.ncbi.nlm.nih.gov/pubmed/18201064 | https://www.ncbi.nlm.nih.gov/pubmed/15219766 | https://www.ncbi.nlm.nih.gov/pubmed/16950502
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11055342
Curator's Comment: description was created based on several sources, including:
https://www.ncbi.nlm.nih.gov/pubmed/18201064 | https://www.ncbi.nlm.nih.gov/pubmed/15219766 | https://www.ncbi.nlm.nih.gov/pubmed/16950502
MS 245 oxalate represents the first member of a novel class of reasonably selective tryptamine-based 5-HT6 receptor antagonists. MS 245 potentiated the hypolocomotor actions, but not the antinociceptive effects, of (-)nicotine in mice. MS 245 together with the ED50 dose of (+)amphetamine resulted in dose-related stimulus generalization. In contrast, the administration of various doses of MS-245 in combination with the ED50 dose of cocaine failed to result in stimulus generalization.
CNS Activity
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL3371 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11055342 |
2.3 nM [Ki] | ||
Target ID: CHEMBL214 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11055342 |
702.0 nM [Ki] | ||
Target ID: CHEMBL3155 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11055342 |
600.0 nM [Ki] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
PubMed
| Title | Date | PubMed |
|---|---|---|
| Effect of the 5-HT(6) serotonin antagonist MS-245 on the actions of (-)nicotine. | 2006-09 |
|
| 1,2,3,4-tetrahydrocarbazoles as 5-HT6 serotonin receptor ligands. | 2004-04-19 |
|
| 2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors. | 2000-03-09 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16950502
5.0, 10 or 15 mg/kg
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11055342
MS-245 produced inhibition of adenylate cyclase activity in a dose-dependent manner (pA2=8.88 0.2 nM).
| Substance Class |
Chemical
Created
by
admin
on
Edited
Tue Apr 01 16:41:00 GMT 2025
by
admin
on
Tue Apr 01 16:41:00 GMT 2025
|
| Record UNII |
L7TKH887Y7
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
MS-245
Created by
admin on Tue Apr 01 16:41:00 GMT 2025 , Edited by admin on Tue Apr 01 16:41:00 GMT 2025
|
PRIMARY | |||
|
DTXSID501027131
Created by
admin on Tue Apr 01 16:41:00 GMT 2025 , Edited by admin on Tue Apr 01 16:41:00 GMT 2025
|
PRIMARY | |||
|
263384-65-2
Created by
admin on Tue Apr 01 16:41:00 GMT 2025 , Edited by admin on Tue Apr 01 16:41:00 GMT 2025
|
PRIMARY | |||
|
L7TKH887Y7
Created by
admin on Tue Apr 01 16:41:00 GMT 2025 , Edited by admin on Tue Apr 01 16:41:00 GMT 2025
|
PRIMARY | |||
|
6918542
Created by
admin on Tue Apr 01 16:41:00 GMT 2025 , Edited by admin on Tue Apr 01 16:41:00 GMT 2025
|
PRIMARY |